α-sinuklein fibril shakllanishini erta bosqichlarda to'xtatish PDni kuchayib borayotgan va patogen α-sinuklein fibrillarining hosil bo'lishini to'xtatish orqali kurashishning samarali yechimi bo'lishi mumkin. 🌟🧬🛡 https://www.sciencedirect.com/science/article/abs/pii/S1047847724000492
#ParkinsonsDisease #NeurodegenerativeDisorders #MolecularDynamics #Research #AlphaSynuclein #ElectricField #EarlyIntervention #ScientificDiscovery #HealthInnovation #BiomedicalResearch
#ParkinsonsDisease #NeurodegenerativeDisorders #MolecularDynamics #Research #AlphaSynuclein #ElectricField #EarlyIntervention #ScientificDiscovery #HealthInnovation #BiomedicalResearch
👍6👏3🔥1👨💻1
🚀 Bugun institutimizga TIQXMMI Milliy Tadqiqot Universiteti rektori Prof. Bakhadir Mirzaev tashrif buyurdi. Institut jamoasi bilan uchrashuv davomida hozirgi yutuqlarimizni hamda kelajakdagi rejalarni muhokama qildik. Katta muvaffaqiyatga erishish va keyingi rivojlanish strategiyalarini belgilash bo'yicha o’z maslahatlari bilan bo’lishdilar. 🌟
🎉 Uchrashuv davomida meni Fundamental va Amaliy Tadqiqotlar Instituti direktori etib tayinladilar. Albatta bu katta mas'uliyat. Nasib bo'lsa institut jamoasi bilan birgalikda mamlakatimizning rivojlanishiga katta hissa qo'shadigan ajoyib natijalarga erishishimizga ishonaman 📈🌍
🎉 Uchrashuv davomida meni Fundamental va Amaliy Tadqiqotlar Instituti direktori etib tayinladilar. Albatta bu katta mas'uliyat. Nasib bo'lsa institut jamoasi bilan birgalikda mamlakatimizning rivojlanishiga katta hissa qo'shadigan ajoyib natijalarga erishishimizga ishonaman 📈🌍
👍24🔥5👏3
Memorandum of Understanding (MoU) Signed Between IFAR and CAT
We are pleased to announce that the Institute of Fundamental and Applied Research (IFAR) at the National Research University TIIAME, represented by its Director, Dr. Jamoliddin Razzokov, has signed a Memorandum of Understanding (MoU) with the Center for Advanced Technologies (CAT) under the Ministry of Higher Education, Science and Innovation, represented by its deputy Director, Dr. Dilbar Dalimova.
This MoU marks the beginning of a collaborative partnership aimed at advancing research in several critical areas, including:
- Plasma Medicine: Leveraging non-thermal plasma (NTP) for cancer treatment through a combination of computer simulations and experimental studies to understand its selective effects on cancer cells.
- Neurological Diseases: Addressing the complexities of diseases such as Parkinson's and Alzheimer's by exploring the impact of electric fields and drugs on amyloid fibers using a blend of in-vitro experiments and computer simulations.
- Artificial Intelligence: Utilizing AI to identify peptide-based inhibitors for proteins involved in various diseases.
- Chronic Wound Healing: Investigating the potential of NTP to accelerate wound healing through combined in-vivo and in-silico studies.
Both IFAR and CAT are committed to sharing resources, expertise, and information to achieve these objectives, with plans for regular meetings, joint publications, and presentations at scientific conferences. This collaboration aims to develop innovative solutions and standards for medical treatments, benefiting the scientific community and patients alike.
We look forward to the groundbreaking research and advancements that will emerge from this partnership over the next five years.
We are pleased to announce that the Institute of Fundamental and Applied Research (IFAR) at the National Research University TIIAME, represented by its Director, Dr. Jamoliddin Razzokov, has signed a Memorandum of Understanding (MoU) with the Center for Advanced Technologies (CAT) under the Ministry of Higher Education, Science and Innovation, represented by its deputy Director, Dr. Dilbar Dalimova.
This MoU marks the beginning of a collaborative partnership aimed at advancing research in several critical areas, including:
- Plasma Medicine: Leveraging non-thermal plasma (NTP) for cancer treatment through a combination of computer simulations and experimental studies to understand its selective effects on cancer cells.
- Neurological Diseases: Addressing the complexities of diseases such as Parkinson's and Alzheimer's by exploring the impact of electric fields and drugs on amyloid fibers using a blend of in-vitro experiments and computer simulations.
- Artificial Intelligence: Utilizing AI to identify peptide-based inhibitors for proteins involved in various diseases.
- Chronic Wound Healing: Investigating the potential of NTP to accelerate wound healing through combined in-vivo and in-silico studies.
Both IFAR and CAT are committed to sharing resources, expertise, and information to achieve these objectives, with plans for regular meetings, joint publications, and presentations at scientific conferences. This collaboration aims to develop innovative solutions and standards for medical treatments, benefiting the scientific community and patients alike.
We look forward to the groundbreaking research and advancements that will emerge from this partnership over the next five years.
👍8
Memorandum of Understanding (MoU) Signed Between IFAR and IGIC
The Institute of Fundamental and Applied Research (IFAR) at the National Research University TIIAME and the Institute of General and Inorganic Chemistry (IGIC) of the Academy of Sciences of Uzbekistan have entered into a strategic partnership through the signing of a Memorandum of Understanding (MoU). The collaboration aims to drive forward research in physical chemistry, inorganic chemistry, nanomaterials, functional crystals, and computational science.
The MoU was officially signed by Dr. Jamoliddin Razzokov, Director of IFAR, and Prof. Aziz Ibragimov, Director of IGIC. This partnership will enable researchers from both institutions to work together on cutting-edge projects that aim to better understand the molecular mechanisms of functional nanomaterials. The ultimate goal is to develop innovative products that could have significant market potential.
Key Areas of Collaboration:
1. Metal Organic Frameworks (MOFs):
o Synthesis and evaluation of MOFs, focusing on their applications in gas adsorption and photocatalysis.
2. Material Processing with Non-Thermal Plasma:
o Modification of materials on the nanometer scale using non-thermal plasma techniques.
3. Carbon and Aluminum Silicate Nanotubes:
o Synthesis and analysis of nanotubes for use in various modern technologies and medical applications.
4. Protein and Ligand Interactions:
o Investigating the inhibitory functions of ligands on target proteins to combat fungi and bacteria.
Both IFAR and IGIC are committed to sharing resources, expertise, and information to achieve these objectives, with plans for regular meetings, joint publications, and presentations at scientific conferences. This collaboration aims to develop innovative solutions to modern problems that would bring benefits to both the social and scientific community.
We look forward to the groundbreaking research and advancements that will emerge from this partnership over the next five years.
The Institute of Fundamental and Applied Research (IFAR) at the National Research University TIIAME and the Institute of General and Inorganic Chemistry (IGIC) of the Academy of Sciences of Uzbekistan have entered into a strategic partnership through the signing of a Memorandum of Understanding (MoU). The collaboration aims to drive forward research in physical chemistry, inorganic chemistry, nanomaterials, functional crystals, and computational science.
The MoU was officially signed by Dr. Jamoliddin Razzokov, Director of IFAR, and Prof. Aziz Ibragimov, Director of IGIC. This partnership will enable researchers from both institutions to work together on cutting-edge projects that aim to better understand the molecular mechanisms of functional nanomaterials. The ultimate goal is to develop innovative products that could have significant market potential.
Key Areas of Collaboration:
1. Metal Organic Frameworks (MOFs):
o Synthesis and evaluation of MOFs, focusing on their applications in gas adsorption and photocatalysis.
2. Material Processing with Non-Thermal Plasma:
o Modification of materials on the nanometer scale using non-thermal plasma techniques.
3. Carbon and Aluminum Silicate Nanotubes:
o Synthesis and analysis of nanotubes for use in various modern technologies and medical applications.
4. Protein and Ligand Interactions:
o Investigating the inhibitory functions of ligands on target proteins to combat fungi and bacteria.
Both IFAR and IGIC are committed to sharing resources, expertise, and information to achieve these objectives, with plans for regular meetings, joint publications, and presentations at scientific conferences. This collaboration aims to develop innovative solutions to modern problems that would bring benefits to both the social and scientific community.
We look forward to the groundbreaking research and advancements that will emerge from this partnership over the next five years.
👍2